218834 RESULTS

Verubecestat Negative Trial Data: What Does it Mean for BACE Inhibition?

CONFERENCE COVERAGE 2017-12-12 Conference Coverage The room was packed at the recent Clinical Trials on Alzheimer’s Disease conference, when Mike Egan of Merck & Co. presented much-anticipated data of EPOCH, the first efficacy trial of his company’s BACE inhibitor verubecestat. An ...

Don’t Be an Enrollment Loser: Throw Your Own Swabapalooza!

CONFERENCE COVERAGE 2017-12-12 Conference Coverage The enormous challenges of recruitment loomed large at the 10th annual Clinical Trials on Amyloid Disease conference, held November 1–4 in Boston. Researchers are seeking new ways of identifying legions of eligible volunteers to enroll ...

Current Filters

No filters selected

Filter By

  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From